provider_review · verified 2026-08-08
Sunlight review
One company, two pricing cultures — and NAD+ got the honest one
The $159 it advertises for NAD+ is the actual month-to-month rate, which is rare here; the $88 it advertises for semaglutide on the same checkout is a $1,196 annual prepay with a coupon on it.
How this site makes money
Plain version: a handful of the outbound links here are affiliate or referral links. Follow one, start a treatment or buy a product, and we may earn a commission — your price stays exactly the same. That money pays for the research, and what we write about any product — and the price you pay — are the same either way. Want the specifics? Read the full disclosure.
at_a_glance
- price
- "$159" on Sunlight's own NAD+ page, alongside a prepay ladder of $447 for three months ($149/mo), $834 for six ($139/mo) and $1,548 for twelve ($129/mo).
- what you pay
- $159 a month, month to month, with no commitment — and this is one of the few rows here where the advertised figure and the standing rate are the same number. The three cheaper figures are real prepay rungs, each labeled with its term.
- pharmacy
- Six named with phone numbers — Belmar, Strive, Epiq Scripts, Casa Pharma Rx, The Pharmacy Hub and Foothills, with Red Rock also referenced — which is the most specific pharmacy disclosure of the five companies added to this site today. None is categorized as 503A or 503B. Clinicians are Lion MD, with Dr Ana Lisa Carr MD (NPI 1689841744) and Dr Kelly Tenbrink MD (NPI 1346482684) published and verifiable. Those are the same two physicians Breeze Meds and Wellorithm publish, because all three run on the same CareValidate white-label backend — so one brand's clinical bench is not independent evidence for another's.
- states
- The company contradicts itself. Its Terms say all 50 states plus Washington DC; its own NAD+ page says all US states except Mississippi. Both are live, and there is no third document that settles which is current.
- on our index
- Ranked #13 of 34 on our NAD+ provider index.
verdict
The short version
Sunlight is the clearest example here of why a price has to be checked per product rather than per company. Its NAD+ line is priced honestly: $159 a month is the month-to-month rung, with genuine prepay discounts beneath it at $149, $139 and $129 a month, and nothing about the advertised figure is a teaser. Its weight-loss line, sold through the same checkout and the same brand, advertises "as low as $88" under the words "same price forever, no hidden fees" — and $88 is a twelve-month prepay of $1,196 with a $140 coupon applied, a figure that appears nowhere in the checkout's own price data. If you are buying NAD+, the number you are shown is the number you pay. What you should carry with you is that the company was willing to write the other sentence, and that its own NAD+ page names an operator under an open FDA warning letter as providing the treatment.
evidence
What the evidence for this route shows
Compounded NAD+ is not an FDA-approved product, and the route sold here has no randomized human trial behind it: there is no published study showing that subcutaneous or intranasal NAD+ raises blood NAD+ in people, let alone that it improves energy, focus or any aging endpoint. What the clinical literature actually supports is the oral precursor NR, which does raise blood NAD+ in controlled trials — a different molecule by a different route. Sunlight sells the injectable route only, so nothing on its menu sits closer to the trial evidence than anything else here — and no dose or strength is published for the injection, which means even the input to that question is unstated.
pricing
What it actually costs
- advertised
- "$159" on Sunlight's own NAD+ page, alongside a prepay ladder of $447 for three months ($149/mo), $834 for six ($139/mo) and $1,548 for twelve ($129/mo).
- you pay
- $159 a month, month to month, with no commitment — and this is one of the few rows here where the advertised figure and the standing rate are the same number. The three cheaper figures are real prepay rungs, each labeled with its term.
- the catch
- None on NAD+, and that is the finding. The trap on this site is on the other side of the same checkout: the weight-loss line advertises "$88" and "$157" as flat monthly rates when both are twelve-month prepays with a $140 coupon applied ($1,196 and $2,020 charged upfront), sold under the words "same price forever" and "no long-term contracts". Neither figure exists in the checkout's own price data. That is not the product this row ranks, but it is the same company writing both sentences.
Other money you will meet
- An $80 clinical fee if you cancel after a clinician has reviewed your intake — waived only if the clinician disqualifies you
- No fee at all if you cancel before that review; the refund is stated as full
- No refund once the prescription reaches the pharmacy
- Cash-pay; no insurance is billed
source :: read at sunlight.com on 2026-08-08, in a browser that runs JavaScript.
fit
Who this is and is not for
Buy it if
- You want a published NAD+ price that is the month-to-month rate rather than the cheapest cell of a prepay ladder
- You want prepay rungs to exist as a real option without being quoted as if they were the standing price
- You want the dispensing pharmacies named — Sunlight names six, with phone numbers
- You want a full refund if you cancel before a clinician has looked at your intake
Look elsewhere if
- You want a provider whose NAD+ page does not name a warning-lettered operator as the party providing the treatment
- You want a company whose pricing language you can trust across its whole catalog, not just the product you came for
- You want to know the dose: no strength is published for the NAD+ injection or the sermorelin
- You want to cancel after a clinician review without an $80 fee that the company's own help center says does not exist
included
What is inside the price
- consult
- Yes — a clinician reviews the intake before anything is dispensed, and the review is inside the subscription rather than billed separately. The sequencing is worth knowing: the $80 clinical fee exists precisely because the review happens before you have decided to stay.
- labs
- Not addressed anywhere on the NAD+ pages, in either direction. No lab is required to start and none is offered.
- follow-ups
- Not itemized. The plan is month to month and cancelable, with no per-visit charge published.
- human support
- Not published as a program. There is no nurse or dietitian offering attached to the peptide line the way there is on the featured row.
- supplies
- Not itemized on the NAD+ page.
- shipping
- Not priced separately on the pages we read.
the_knock
What they would rather you skipped
Sunlight's own NAD+ page states that "every NAD+ treatment provided through Direct Meds is reviewed and approved by a licensed healthcare professional." Direct Meds is a different company — directmeds.com, Inc. dba DirectMeds — and it received an FDA warning letter in September 2025. We review Direct Meds elsewhere on this site and disclose the letter there too. Sunlight itself is clean; what its page does is name a warning-lettered operator as the entity providing the treatment you would be buying, in a sentence that reads as reassurance. The likeliest explanation is an un-scrubbed brand string from a sibling tenant on the shared backend both companies use, which is its own problem: a page that has not been read closely enough to remove another company's name is not a page whose claims have been checked. The second knock is the $80 cancellation fee, which does not merely go undisclosed on the marketing pages — it is contradicted by them. Sunlight's own help center answers "are there any costs besides the monthly subscription?" with "no … there are no hidden fees." A fee that appears only after a clinician has reviewed you, on a site that has told you in writing there are none, is exactly the thing this site exists to print. And we earn a commission when a reader starts care through our link, which is why both paragraphs are here rather than in a footnote.
And the rest
- Sunlight's own NAD+ page names Direct Meds — an operator carrying an FDA warning letter from September 2025 — as providing the treatment
- An $80 clinical fee on cancellation after clinician review, directly contradicting its own help-center article promising no hidden fees
- Its weight-loss line advertises twelve-month prepay rungs as flat monthly rates under the words "same price forever", and neither advertised figure exists in the checkout's own data
- Two of the company's own funnels disagree on price, and a third page still quotes a semaglutide rate the checkout abandoned
- The Terms and the NAD+ page disagree about which states are served
- No dose or strength is published for the NAD+ injection, and no 503A/503B designation for any of the six named pharmacies
- "Over 100,000 Happy Customers" and a "98% Patient Success Rate" carry no source, method or denominator
tools
Work out your own number
Every figure on this page was read on Sunlight’s own site on 2026-08-08 in a browser that runs JavaScript, and prices change without notice. Compare it against the rest of the field on our NAD+ provider index, or read every provider review.
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.